The Latest in Gynecologic Cancer

Oncology Practice

In recurrent ovarian cancer, secondary surgery does not extend survival

November 18, 2019

Gynecologic Cancer

Oncology Practice

Surgical staging improves cervical cancer outcomes

November 14, 2019

Gynecologic Cancer

Oncology Practice

Sentinel node biopsy safe for women with vulval cancer

November 13, 2019

Gynecologic Cancer

Oncology Practice

Molecule exhibits activity in heavily pretreated, HER2-positive solid tumors

November 11, 2019

Oncology Practice

Disparity in endometrial cancer outcomes: What can we do?

November 1, 2019

Gynecologic Cancer

Oncology Practice

USPSTF recommendations on risk assessment, genetic counseling, and genetic testing for BRCA-related cancer

October 28, 2019

Is it time to expand the use of PARP inhibitors?

October 25, 2019

Oncology Practice

Veliparib improves PFS in high-grade serous epithelial ovarian cancer

October 17, 2019

Gynecologic Cancer

The law of unintended consequences

October 11, 2019

Oncology Practice

Pilot program benefits gynecologic cancer patients with malignant bowel obstruction

October 10, 2019

Oncology Practice

PRIMA study: Niraparib maintenance improves PFS in advanced OC

October 8, 2019

Gynecologic Cancer

Oncology Practice

PAOLA-1/ENGOT-ov25 trial: PARP inhibitor for maintenance improves PFS in advanced ovarian cancer

September 29, 2019

Gynecologic Cancer

Oncology Practice

BAROCCO study: Cediranib-olaparib combination shows promise in PROC

September 28, 2019

Gynecologic Cancer

Oncology Practice

Closure of women’s health clinics may negatively impact cervical cancer outcomes

September 22, 2019

Oncology Practice

FDA approves pembrolizumab/lenvatinib combo for advanced endometrial carcinoma

September 17, 2019

Gynecologic Cancer